STEVEN D GOLDBY
CIK 1216626 · Chairman of the Board · last filed 2019-05-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.8K
Companies
4
Total Filings
36
Lifetime Open-Market Net
$224.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | 73,137 | $8.76 | $640.7K | $224.8K | 23 | 2019-05-30 |
| ACCL | Director | 7,950 | $1.61 | $12.8K | $0 | 3 | 2011-08-05 |
| SYMYX TECHNOLOGIES INC (SMMX) Delisted | Chairman of the Board | 64,845 | — | — | $0 | 7 | 2009-06-15 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | Director | — | $18.62 | — | $0 | 2 | 2008-06-06 |
Recent Filings · Page 3 of 4
36 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-05-27 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Exer (M) | +1,667 | $0 | EDGAR |
| 2011-05-24 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Exer (M) | — | $0 | EDGAR |
| 2010-08-05 | ACCL | Grant (A) | +18,000 | $0 | EDGAR |
| 2010-07-06 | ACCL | Grant (A) | +50,591 | $0 | EDGAR |
| 2010-07-06 | — | Disp (D) | −64,845 | $0 | |
| 2010-05-28 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Exer (M) | — | $0 | EDGAR |
| 2009-06-15 | SYMYX TECHNOLOGIES INC (SMMX) Delisted | Other (J) | +8,403 | $0 | EDGAR |
| 2009-05-26 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-05 | SYMYX TECHNOLOGIES INC (SMMX) Delisted | Mixed | +12,716 | $31.3K | EDGAR |
| 2008-06-06 | Viracta Therapeutics, Inc. (SNSS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.